Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dexcom (DXCM) Enterprise Value (2016 - 2025)

Dexcom (DXCM) has disclosed Enterprise Value for 16 consecutive years, with -$917.7 million as the latest value for Q4 2025.

  • Quarterly Enterprise Value fell 583.83% to -$917.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$917.7 million through Dec 2025, down 583.83% year-over-year, with the annual reading at -$917.7 million for FY2025, 583.83% down from the prior year.
  • Enterprise Value for Q4 2025 was -$917.7 million at Dexcom, up from -$1.8 billion in the prior quarter.
  • The five-year high for Enterprise Value was -$134.2 million in Q4 2024, with the low at -$1.8 billion in Q3 2025.
  • Average Enterprise Value over 5 years is -$878.6 million, with a median of -$793.3 million recorded in 2022.
  • The sharpest move saw Enterprise Value surged 76.3% in 2024, then crashed 583.83% in 2025.
  • Over 5 years, Enterprise Value stood at -$1.1 billion in 2021, then soared by 38.98% to -$642.3 million in 2022, then rose by 11.83% to -$566.3 million in 2023, then soared by 76.3% to -$134.2 million in 2024, then plummeted by 583.83% to -$917.7 million in 2025.
  • According to Business Quant data, Enterprise Value over the past three periods came in at -$917.7 million, -$1.8 billion, and -$1.2 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.